FASEB bioAdvances
FASEB bioAdvances
ISSNs: 2573-9832
Additional searchable ISSN (Electronic): 2573-9832
Journal
Research Output
- 2020
- Published
Depleting interferon regulatory factor-1(IRF-1) with CRISPR/Cas9 attenuates inducible oxidative metabolism without affecting RA-induced differentiation in HL-60 human AML cells
Zhu, K., Yue, J. & Yen, A., Jun 2020, In : FASEB bioAdvances. 2, 6, p. 354-364 11 p.Research output: Journal Publications and Reviews (RGC: 21, 22, 62) › 21_Publication in refereed journal › peer-review
